In last trading session, Leap Therapeutics Inc (NASDAQ:LPTX) saw 0.3 million shares changing hands with its beta currently measuring 0.32. Company’s recent per share price
During the last session, Leap Therapeutics Inc (NASDAQ:LPTX)’s traded shares were 0.42 million, with the beta value of the company hitting 0.32. At the end
In the last trading session, 1.03 million shares of the Leap Therapeutics Inc (NASDAQ:LPTX) were traded, and its beta was 0.32. Most recently the company’s
Leap Therapeutics Inc (NASDAQ:LPTX)’s traded shares stood at 1.22 million during the last session, with the company’s beta value hitting 0.32. At the close of
In the last trading session, 1.1 million Leap Therapeutics Inc (NASDAQ:LPTX) shares changed hands as the company’s beta touched 0.12. With the company’s per share
Leap Therapeutics Inc (NASDAQ:LPTX) has a beta value of 0.21 and has seen 12.57 million shares traded in the last trading session. The company, currently
Leap Therapeutics Inc (NASDAQ:LPTX) has a beta value of 0.21 and has seen 4.43 million shares traded in the recent trading session. The company, currently
During the last session, Leap Therapeutics Inc (NASDAQ:LPTX)’s traded shares were 0.44 million, with the beta value of the company hitting 0.18. At the end
Leap Therapeutics Inc (NASDAQ:LPTX)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 0.22. At the close of
In last trading session, Leap Therapeutics Inc (NASDAQ:LPTX) saw 0.33 million shares changing hands with its beta currently measuring 0.48. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
